Martin Johansson
Algemeen Directeur bij Glactone Pharma AB
Actieve functies van Martin Johansson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Lund | Corporate Officer/Principal | - | - |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Algemeen Directeur | 01-01-2012 | - |
| Oprichter | 01-01-2012 | - |
Loopbaan van Martin Johansson
Eerdere bekende functies van Martin Johansson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | - |
| Corporate Officer/Principal | - | 01-01-2011 |
Statistieken
Internationaal
| Zweden | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
 | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
- Beurs
- Insiders
- Martin Johansson
- Ervaring
